These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30775826)

  • 21. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
    Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
    Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
    Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
    Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Husain ZA; Chen T; Corso CD; Wang Z; Park H; Judson B; Yarbrough W; Deshpande H; Mehra S; Kuo P; Decker RH; Burtness BA
    JAMA Oncol; 2017 Mar; 3(3):358-365. PubMed ID: 27737449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
    Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
    Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Horwich P; Gundale A; Patin S; Flores J; Moore Medlin T; Chang BA; Nathan CO
    Head Neck; 2021 Sep; 43(9):2698-2704. PubMed ID: 34002904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.
    Xu MJ; Lazar AA; Garsa AA; Arron ST; Ryan WR; El-Sayed IH; George JR; Algazi AP; Heaton CM; Ha PK; Yom SS
    Head Neck; 2018 Jul; 40(7):1406-1414. PubMed ID: 29524273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
    Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.
    Cheraghlou S; Yu PK; Otremba MD; Park HS; Bhatia A; Zogg CK; Mehra S; Yarbrough WG; Judson BL
    Cancer; 2018 Feb; 124(4):717-726. PubMed ID: 29243245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.
    Sandulache VC; Hamblin J; Lai S; Pezzi T; Skinner HD; Khan NA; Dioun SM; Hartman C; Kramer J; Chiao E; Zhou X; Zevallos JP
    Head Neck; 2015 Sep; 37(9):1246-53. PubMed ID: 24801106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
    Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
    Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):568-75. PubMed ID: 27077485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus and survival of patients with oropharyngeal cancer.
    Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
    N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.
    Floberg JM; DeWees TA; Chin RI; Garsa AA; Dehdashti F; Nussenbaum B; Oppelt PJ; Adkins DR; Gay HA; Thorstad WL
    Head Neck; 2018 Oct; 40(10):2280-2287. PubMed ID: 30051553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.